Lilly's Zepbound for Sleep Apnea Treatment Now Covered Under Medicare

Gelonghui January 9 | According to CNBC's report on Wednesday, citing the U.S. Centers for Medicare & Medicaid Services, the obesity drug Zepbound produced by Eli Lilly and Company, which American consumers purchase for treating sleep apnea, can be included in the Medicare plan.